Seth Klarman's position in Jazz Pharmaceuticals plc is currently worth $91.5 Million. That's 3.01% of their equity portfolio (7th largest holding). The investor owns 1.28% of the outstanding Jazz Pharmaceuticals plc stock. The investor's estimated purchase price is $117 Million, resulting in a loss of 22%.